Environment
-

Pharmaceutical Companies Race to Develop COVID-19 Antiviral Pill: Will it Work?
Seeing huge progress in vaccine technology and development, there's more hope in speeding up antiviral pipelines through development of working Covid-19 pills. In fact, Merck & Co., Inc., an American multinational pharmaceutical company, anticipates authorization for its oral COVID-19 antiviral drug, molnupiravir, by the end of the year, November as earliest.
Latest Research Articles
-

Imaging Technology Reveals Hidden Ancient Maya City with Buildings
-

Amazon and Apple Among Big Corporations Blocking New US Climate Bill
-

California Woman Trying to Boil Bear Pee Arrested for Sparking Wildfire That Raged Thousands of Acre
-

Kilauea Volcano: Lava Eruption is Sending 'Pele's Hair' into Hawaii's Skies
-

Hurricane Season is Not Slowing Down: Tropical Storm Victor is Brewing in the Eastern Atlantic
-

Pregnant Mom Lost Unborn Baby Due to Infection From Pet Cat's Feces
-

Glastonbury: Drug Traces in Pee of Festival Goers Could Harm Aquatic Creatures
-

Australia’s Daintree: World’s Oldest Tropical Rainforest Returned to its Aboriginal People
Experts Warn Pet Owners to be Vigilant of Hookworms, a Parasite Immune to All Treatments
Ivory-Billed Woodpecker, Several Other Birds and Fishes Declared Extinct by U.S. Government
-

Massive Dust Storm in Brazil Turned Day Into Night, Swallowing Cities in Clouds of Dust
-

Man in Arizona in Critical Condition After Being Aggressively Stung by a Swarm of Bees






